Ayurveda tech startup NirogStreet snaps up $12M in Series B funding
NirogStreet, an Ayurveda technology platform in India, has scored $12 million in a Series B funding round led by Jungle Ventures.
It provides a community for Ayurveda doctors and an e-commerce platform that streamlines the supply chain of Ayurvedic services and medicine. NirogStreet has onboarded around 50,000 medical practitioners and about 50 Ayurveda brands.
The startup will use the proceeds from its latest investing round to bolster its supply chain, technology, and services.
Want to publish your own articles on DistilINFO Publications?
Send us an email, we will get in touch with you.
Men’s health startup Bonatra obtains pre-seed funding
Bonatra, a men’s health-focused startup from India, has raised INR 55 million ($670,000) in a pre-seed funding round led by ITI Growth Opportunities Fund with the participation of marquee angel investors, Jitendra Jagadev, founder of Nestaway, and Blackbuck founder Rajesh Yabaji.
The company runs a technology platform that offers personalised health programmes targeting chronic conditions of men.
In a statement, Bonatra said that its fresh funds will be used to expand its offerings, build its team, and grow its client base.
Edenlux introduces AI report to its mobile eye health app
South Korean medical device maker Edenlux is now providing AI-generated eye health management reports through its flagship mobile app Otus Plus.
The app allows users to test their eye health with a paired goggle device, do gamified eye exercises, and receive an eye health report.
Its eye health reports now contain AI-generated eye health scores, analysis of eye focus reaction speed, and results of eye exercise games based on users’ data.
In the future, Edenlux plans to add an improvement indicator to its reports, as well as offer a service that allows users to choose their own customised lenses for eye exercises and use accumulated data to provide an eye health score report.
Cha Vaccine ties up with MOGAM for AI drug discovery
The MOGAM Institute for Biomedical Research has signed a memorandum of understanding with the Cha Vaccine Institute for AI drug discovery.
They will cooperate to develop new drugs and improve drug substances using MOGAM’s AI algorithms, which will be tested using medical data from Cha Vaccine. Later, they will conduct joint studies and apply for co-patents.
Source: Mobile Health News
